|
33371.02.01
|
AKEEGA F.C.TAB (100+500)MG/TAB BT X 56 ΔΙΣΚΙΑ ΣΕ BLISTERS (PVDC/PE/PVC/ALU)
|
|
4.201,05 |
4.672,44 |
5.051,84 |
Janssen-Cilag International NV
|
|
33371.01.01
|
AKEEGA F.C.TAB (50+500)MG/TAB BT X 56 ΔΙΣΚΙΑ ΣΕ BLISTERS (PVDC/PE/PVC/ALU)
|
|
4.201,05 |
4.672,44 |
5.051,84 |
Janssen-Cilag International NV
|
|
30458.01.01
|
DACOGEN PD.C.S.INF 50MG/VIAL BTx1 VIAL x 20ML
|
|
934,84 |
1.039,74 |
1.157,23 |
Janssen-Cilag International NV
|
|
31427.01.01
|
DARZALEX C/S.SOL.IN 100mg/5ml VIAL BTx1 VIAL x5 ML
|
|
322,80 |
359,03 |
418,63 |
Janssen-Cilag International NV
|
|
31427.02.01
|
DARZALEX C/S.SOL.IN 400mg/20ml VIAL BTx1 VIAL x20 ML
|
|
1.294,04 |
1.439,23 |
1.590,42 |
Janssen-Cilag International NV
|
|
31427.04.01
|
DARZALEX INJ.SOL 1800MG/VIAL (120 MG/ML) BTx1VIAL x 15ML
|
|
3.959,03 |
4.403,26 |
4.760,81 |
Janssen-Cilag International NV
|
|
28477.01.01
|
DORIBAX PD.SOL.INF 500MG/VIAL BTx10VIALS
|
|
153,23 |
176,14 |
212,85 |
Janssen-Cilag International NV
|
|
30175.01.01
|
EDURANT F.C.TAB 25MG/TAB BTx1HDPE VIALx30TABS
|
|
163,62 |
188,07 |
227,26 |
Janssen-Cilag International NV
|
|
32060.01.01
|
ERLEADA F.C.TAB 60MG/TAB BTx112 δισκία σε blisters PVC/PCTFE/alu
|
|
2.197,35 |
2.443,91 |
2.661,79 |
Janssen-Cilag International NV
|
|
25245.01.02
|
EVRA 60MG+600MC ΦΑΚΕΛΛΙΣΚΟΣ -9 ΔΙΑ-
|
|
17,42 |
20,02 |
28,23 |
Janssen-Cilag International NV
|
|
25245.01.01
|
EVRA 60MG+600MC ΦΑΚΕΛΛΙΣΚΟΣ- 3 ΔΙΑ-
|
|
5,00 |
5,75 |
8,11 |
Janssen-Cilag International NV
|
|
30943.01.02
|
IMBRUVICA CAPS 140MG/CAP BTx1 (HDPE) BOTTLE x120
|
|
6.134,83 |
6.823,21 |
7.377,25 |
Janssen-Cilag International NV
|
|
30943.01.01
|
IMBRUVICA CAPS 140MG/CAP BTx1 (HDPE) BOTTLE x90
|
|
4.442,93 |
4.941,46 |
5.342,71 |
Janssen-Cilag International NV
|
|
30943.04.02
|
IMBRUVICA F.C.TAB 140MG/ΤAΒ BTx30x1 δισκία (μοναδιαία δόση) σε BLISTERS PVC/PCTFE/alu
|
|
1.480,98 |
1.645,15 |
1.811,46 |
Janssen-Cilag International NV
|
|
30943.05.02
|
IMBRUVICA F.C.TAB 280MG/ΤΑΒ BTx30x1 δισκία (μοναδιαία δόση) σε BLISTERS PVC/PCTFE/alu
|
|
2.961,95 |
3.294,30 |
3.561,80 |
Janssen-Cilag International NV
|
|
30943.02.01
|
IMBRUVICA F.C.TAB 420MG/ΤΑΒ BTx30x1 δισκία (μοναδιαία δόση) σε BLISTERS PVC/PCTFE/alu
|
|
4.442,93 |
4.941,46 |
5.342,70 |
Janssen-Cilag International NV
|
|
30943.03.01
|
IMBRUVICA F.C.TAB 560MG/ΤΑΒ BTx30x1 δισκία (μοναδιαία δόση) σε BLISTERS PVC/PCTFE/alu
|
|
6.060,61 |
6.740,66 |
7.288,00 |
Janssen-Cilag International NV
|
|
30021.01.01
|
INCIVO F.C.TAB 375MG/TAB BTx168 TABS [4 BOTTLES(HDPE)x42]
|
|
7.039,79 |
7.829,70 |
8.465,47 |
Janssen-Cilag International NV
|
|
30021.01.02
|
INCIVO F.C.TAB 375MG/TAB BTx42 TABS [1 BOTTLE (HDPE)x42]
|
|
1.813,64 |
2.017,14 |
2.202,31 |
Janssen-Cilag International NV
|
|
28563.01.01
|
INTELENCE TAB 100MG/TAB Φιάλη (HPDE) x 120
|
|
322,30 |
358,48 |
417,99 |
Janssen-Cilag International NV
|
|
28563.02.01
|
INTELENCE TAB 200MG/TAB Φιάλη (HPDE) x 60
|
|
288,19 |
320,53 |
373,73 |
Janssen-Cilag International NV
|
|
27892.01.04
|
INVEGA 3MG/TAB BT x 56 σε BLISTERS
|
|
74,20 |
85,29 |
120,26 |
Janssen-Cilag International NV
|
|
27892.02.04
|
INVEGA 6MG/TAB BT x 56 σε BLISTERS
|
|
76,24 |
87,63 |
123,56 |
Janssen-Cilag International NV
|
|
27892.03.04
|
INVEGA 9MG/TAB BT x 56 σε BLISTERS
|
|
80,85 |
92,93 |
131,04 |
Janssen-Cilag International NV
|
|
27892.01.11
|
INVEGA PR.TAB 3MG/TAB BT x 28 σε BLISTERS (OPA-ALU-PVC/ALU) (OPA-ALU-PVC/ALU)
|
|
49,21 |
56,56 |
71,94 |
Janssen-Cilag International NV
|
|
27892.01.01
|
INVEGA PR.TAB 3MG/TAB BT x 28 σε BLISTERS (PVC/PCTFE/ALU) (PVC/PCTFE/ALU)
|
|
52,91 |
60,82 |
77,36 |
Janssen-Cilag International NV
|
|
27892.02.11
|
INVEGA PR.TAB 6MG/TAB BT x 28 σε BLISTERS (OPA-ALU-PVC/ALU) (OPA-ALU-PVC/ALU)
|
|
50,87 |
58,47 |
74,37 |
Janssen-Cilag International NV
|
|
27892.02.01
|
INVEGA PR.TAB 6MG/TAB BT x 28 σε BLISTERS (PVC/PCTFE/ALU) (PVC/PCTFE/ALU)
|
|
54,70 |
62,88 |
79,99 |
Janssen-Cilag International NV
|
|
27892.03.11
|
INVEGA PR.TAB 9MG/TAB BT x 28 σε BLISTERS (OPA-ALU-PVC/ALU) (OPA-ALU-PVC/ALU)
|
|
55,29 |
63,56 |
80,85 |
Janssen-Cilag International NV
|
|
27892.03.01
|
INVEGA PR.TAB 9MG/TAB BT x 28 σε BLISTERS (PVC/PCTFE/ALU) (PVC/PCTFE/ALU)
|
|
59,47 |
68,35 |
86,94 |
Janssen-Cilag International NV
|
|
30680.01.02
|
INVOKANA F.C.TAB 100MG/TAB BTx30 δισκία
|
|
30,39 |
34,93 |
48,13 |
Janssen-Cilag International NV
|
|
30680.02.02
|
INVOKANA F.C.TAB 300MG/TAB BTx30 δισκία
|
|
37,30 |
42,87 |
59,07 |
Janssen-Cilag International NV
|
|
27339.01.01
|
IONSYS ITS 40MCG/DOSE BTx1 SACHET (NAYLON/ALU)
|
|
43,72 |
50,25 |
70,85 |
Janssen-Cilag International NV
|
|
|
JANSSEN COVID-19 INJ_SUSP 2.5ML/VIAL x 10 VIALS x 5 δόσεις
|
|
|
|
|
Janssen-Cilag International NV
|
|
|
JANSSEN COVID-19 INJ_SUSP 2.5ML/VIAL x 20 VIALS x 5 δόσεις
|
|
|
|
|
Janssen-Cilag International NV
|
|
30792.01.02
|
OLYSIO CAPS 150MG/CAP BTx28 (PVC/PE/PVDC/Alu blister)
|
|
6.470,22 |
7.196,21 |
7.780,54 |
Janssen-Cilag International NV
|
|
30792.01.01
|
OLYSIO CAPS 150MG/CAP BTx7 (PVC/PE/PVDC/Alu blister)
|
|
1.709,78 |
1.901,67 |
2.081,28 |
Janssen-Cilag International NV
|
|
30717.01.02
|
OPSUMIT F.C.TAB 10MG/TAB BTx30 (PVC/PE/PVdC/ALU blister)
|
|
1.475,64 |
1.641,21 |
1.804,93 |
Janssen-Cilag International NV
|
|
32781.01.01
|
PONVORY F.C.TAB 10MG/TAB συσκευασία έναρξης ΣΥΣΚΕΥΑΣΙΑ ΕΝΑΡΞΗΣ ΘΕΡΑΠΕΙΑΣ: 14 ΔΙΣΚΙΑ ΤΩΝ (2X2MG+2X3MG+2X4MG+1X5MG+1X6MG+1X7MG+1X8MG+1X9MG+3X10MG) ΣΕ BLISTERS OPA/ALU/PE+DES/PET/ALU/PE
|
|
562,98 |
626,15 |
710,18 |
Janssen-Cilag International NV
|
|
32781.02.01
|
PONVORY F.C.TAB 20MG/TAB συσκευασία συντήρησης 28 ΔΙΣΚΙΑ ΣΕ BLISTERS OPA/ALU/PE+DES/PET/ALU/PE
|
|
1.125,96 |
1.252,30 |
1.383,85 |
Janssen-Cilag International NV
|
|
27701.01.01
|
PREZISTA 300MG/TAB F.C.TAB Φιάλη (HDPE) x 120
|
|
548,67 |
630,66 |
703,60 |
Janssen-Cilag International NV
|
|
27701.03.01
|
PREZISTA F.C.TAB 400MG/TAB Φιάλη (HDPE)x60
|
|
317,63 |
353,27 |
411,92 |
Janssen-Cilag International NV
|
|
27701.02.01
|
PREZISTA F.C.TAB 600MG/TAB Φιάλη (HDPE)x60
|
|
323,82 |
360,15 |
419,94 |
Janssen-Cilag International NV
|
|
27701.05.01
|
PREZISTA F.C.TAB 800MG/TAB Φιάλη (HDPE) x 30
|
|
216,35 |
240,63 |
285,68 |
Janssen-Cilag International NV
|
|
31123.01.01
|
REZOLSTA F.C.TAB (800+150)MG/TAB Φιάλη (HDPE) x 30 δισκία
|
|
331,78 |
369,01 |
430,26 |
Janssen-Cilag International NV
|
|
32949.01.01
|
RYBREVANT C/S.SOL.IN 350MG/7ML BT X 1 VIAL X 7 ML
|
|
1.080,62 |
1.201,87 |
1.337,68 |
Janssen-Cilag International NV
|
|
32299.01.01
|
SPRAVATO NASPR.SOL 28MG 1 περιέκτης εκνεφώματος (VIAL)
|
|
167,59 |
192,64 |
232,79 |
Janssen-Cilag International NV
|
|
31056.02.03
|
STAYVEER F.C.TAB 125MG/TAB BTx HDPE BOTTLE x56
|
|
545,00 |
606,15 |
687,49 |
Janssen-Cilag International NV
|
|
31056.02.01
|
STAYVEER F.C.TAB 125MG/TAB BTx56 σε BLISTER PVC/PE/PVDC/Alu
|
|
545,00 |
606,15 |
687,49 |
Janssen-Cilag International NV
|
|
31056.01.03
|
STAYVEER F.C.TAB 62.5MG/TAB BTx HDPE BOTTLE x56
|
|
553,79 |
615,93 |
698,59 |
Janssen-Cilag International NV
|
|
31056.01.01
|
STAYVEER F.C.TAB 62.5MG/TAB BTx56 σε BLISTER PVC/PE/PVDC/Alu
|
|
553,79 |
615,93 |
698,59 |
Janssen-Cilag International NV
|
|
28717.05.01
|
STELARA C/S.SOL.IN 130MG/26ML VIAL (5MG/ML) BTx1VIALx26 ML
|
|
1.826,99 |
2.031,99 |
2.218,53 |
Janssen-Cilag International NV
|
|
28717.06.01
|
STELARA IN.SO.PF.P 45MG/0,5ML (90MG/ML) BTx1PF.PEN x0,5ML
|
|
1.825,28 |
2.030,09 |
2.216,45 |
Janssen-Cilag International NV
|
|
28717.07.01
|
STELARA IN.SO.PF.P 90MG/1ML BTx1PF.PEN x1ML
|
|
1.825,57 |
2.030,40 |
2.216,79 |
Janssen-Cilag International NV
|
|
28717.03.01
|
STELARA INJ.SO.PFS 45MG/(90mg/ml) 0.5ML PF.SYR. BTx1PF SYRx0,5ML
|
|
1.825,28 |
2.030,09 |
2.216,45 |
Janssen-Cilag International NV
|
|
28717.04.01
|
STELARA INJ.SO.PFS 90MG/1ML BTx1PF SYRx1,0ML
|
|
1.825,57 |
2.030,40 |
2.216,79 |
Janssen-Cilag International NV
|
|
28717.01.01
|
STELARA INJ.SOL 45MG (90MG/ML)/0,5ML VIAL BTx1 VIALx 0,5ML
|
|
2.224,62 |
2.474,24 |
2.694,82 |
Janssen-Cilag International NV
|
|
30857.01.01
|
SYLVANT PD.C.S.INF 100MG/VIAL BTx1 VIAL (glass)
|
|
426,46 |
474,31 |
548,02 |
Janssen-Cilag International NV
|
|
30857.02.01
|
SYLVANT PD.C.S.INF 400MG/VIAL BTx1 VIAL (glass)
|
|
1.764,99 |
1.963,03 |
2.148,44 |
Janssen-Cilag International NV
|
|
31757.01.01
|
SYMTUZA F.C.TAB (800+150+200+10)MG/TAB HDPE Bottle x 30 TABS
|
|
600,41 |
667,78 |
757,39 |
Janssen-Cilag International NV
|
|
33504.01.01
|
TALVEY INJ.SOL 2MG/ML BT X 1 VIAL X 1.5ML
|
|
352,70 |
392,28 |
457,40 |
Janssen-Cilag International NV
|
|
33504.02.01
|
TALVEY INJ.SOL 40MG/ML BT X 1 VIAL X 1ML
|
|
4.702,70 |
5.230,37 |
5.655,08 |
Janssen-Cilag International NV
|
|
33147.01.01
|
TECVAYLI INJ.SOL 10MG/ML VIAL BT X 1 VIAL X 3 ML
|
|
813,52 |
904,80 |
1.011,83 |
Janssen-Cilag International NV
|
|
33147.02.01
|
TECVAYLI INJ.SOL 90MG/ML VIAL BT X 1 VIAL X 1.7 ML
|
|
4.148,83 |
4.614,36 |
4.989,05 |
Janssen-Cilag International NV
|
|
25213.02.01
|
TRACLEER F.C.TAB 125MG/TAB BTX56
|
|
697,08 |
775,30 |
875,23 |
Janssen-Cilag International NV
|
|
25213.01.02
|
TRACLEER F.C.TAB 62,5MG/TAB BTX56
|
|
677,06 |
753,03 |
850,10 |
Janssen-Cilag International NV
|
|
31791.01.02
|
TREMFYA INJ.SOL 100MG/1ML 1 PF.PEN x1 ML
|
|
1.465,35 |
1.629,78 |
1.792,35 |
Janssen-Cilag International NV
|
|
31791.01.01
|
TREMFYA INJ.SOL 100MG/1ML 1 PF.SYR x1 ML
|
|
1.747,22 |
1.943,27 |
2.126,82 |
Janssen-Cilag International NV
|
|
31487.02.01
|
TREVICTA INJ.SU.PRO 263MG/PF SYR 1 PFSYR x 1,315 ML (200MG/ML) + 2 βελόνες
|
|
429,54 |
477,74 |
551,98 |
Janssen-Cilag International NV
|
|
31487.03.01
|
TREVICTA INJ.SU.PRO 350MG/PF SYR 1 PFSYR x 1,750 ML (200MG/ML) + 2 βελόνες
|
|
528,71 |
588,04 |
673,18 |
Janssen-Cilag International NV
|
|
31487.04.01
|
TREVICTA INJ.SU.PRO 525MG/PF SYR 1 PFSYR x 2,625 ML (200MG/ML) + 2 βελόνες
|
|
793,05 |
882,03 |
991,05 |
Janssen-Cilag International NV
|
|
31487.01.01
|
TREVICTA INJ.SU.RET 175MG/PF SYR 1 PFSYR x 0,875 ML (200MG/ML) + 2 βελόνες
|
|
414,17 |
460,65 |
532,24 |
Janssen-Cilag International NV
|
|
31418.05.01
|
UPTRAVI F.C.TAB 1000MCG/TAB BTx60 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU)
|
|
2.089,12 |
2.323,54 |
2.530,69 |
Janssen-Cilag International NV
|
|
31418.06.01
|
UPTRAVI F.C.TAB 1200MCG/TAB BTx60 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU)
|
|
2.089,12 |
2.323,54 |
2.530,69 |
Janssen-Cilag International NV
|
|
31418.07.01
|
UPTRAVI F.C.TAB 1400MCG/TAB BTx60 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU)
|
|
2.089,12 |
2.323,54 |
2.530,69 |
Janssen-Cilag International NV
|
|
31418.08.01
|
UPTRAVI F.C.TAB 1600MCG/TAB BTx60 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU)
|
|
2.089,12 |
2.323,54 |
2.530,69 |
Janssen-Cilag International NV
|
|
31418.01.03
|
UPTRAVI F.C.TAB 200MCG/TAB BTx140 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU) (συσκευασία τιτλοποίησης)
|
|
4.939,24 |
5.493,45 |
5.939,52 |
Janssen-Cilag International NV
|
|
31418.01.02
|
UPTRAVI F.C.TAB 200MCG/TAB BTx60 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU)
|
|
2.089,12 |
2.323,54 |
2.530,69 |
Janssen-Cilag International NV
|
|
31418.02.01
|
UPTRAVI F.C.TAB 400MCG/TAB BTx60 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU)
|
|
2.089,12 |
2.323,54 |
2.530,69 |
Janssen-Cilag International NV
|
|
31418.03.01
|
UPTRAVI F.C.TAB 600MCG/TAB BTx60 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU)
|
|
2.089,12 |
2.323,54 |
2.530,69 |
Janssen-Cilag International NV
|
|
31418.04.01
|
UPTRAVI F.C.TAB 800MCG/TAB BTx60 δισκία σε BLISTERS (PA/Alu/HDPE/PE/ALU)
|
|
2.089,12 |
2.323,54 |
2.530,69 |
Janssen-Cilag International NV
|
|
26548.01.01
|
VELCADE PD.INJ.SOL 3,5MG/VIAL BTX1VIAL
|
|
550,28 |
612,02 |
694,15 |
Janssen-Cilag International NV
|
|
30825.04.01
|
VOKANAMET F.C.TAB (150+1000)mg/TAB HDPE BOTTLE x20
|
|
22,17 |
25,48 |
35,10 |
Janssen-Cilag International NV
|
|
30825.04.02
|
VOKANAMET F.C.TAB (150+1000)mg/TAB HDPE BOTTLE x60
|
|
46,31 |
53,24 |
67,72 |
Janssen-Cilag International NV
|
|
30825.03.01
|
VOKANAMET F.C.TAB (150+850)mg/TAB HDPE BOTTLE x20
|
|
22,35 |
25,69 |
35,40 |
Janssen-Cilag International NV
|
|
30825.03.02
|
VOKANAMET F.C.TAB (150+850)mg/TAB HDPE BOTTLE x60
|
|
49,80 |
57,24 |
72,81 |
Janssen-Cilag International NV
|
|
30825.02.01
|
VOKANAMET F.C.TAB (50+1000)mg/TAB HDPE BOTTLE x20
|
|
13,88 |
15,95 |
21,99 |
Janssen-Cilag International NV
|
|
30825.02.02
|
VOKANAMET F.C.TAB (50+1000)mg/TAB HDPE BOTTLE x60
|
|
33,81 |
38,87 |
53,56 |
Janssen-Cilag International NV
|
|
30825.01.01
|
VOKANAMET F.C.TAB (50+850)mg/TAB HDPE BOTTLE x20
|
|
13,84 |
15,90 |
21,91 |
Janssen-Cilag International NV
|
|
30825.01.02
|
VOKANAMET F.C.TAB (50+850)mg/TAB HDPE BOTTLE x60
|
|
34,20 |
39,32 |
54,19 |
Janssen-Cilag International NV
|
|
29815.04.01
|
XEPLION INJ.SU.PRO 100MG/PF.SYR BTx1PF.SYRx100MG +2 βελόνες +2 βελόνες
|
|
182,84 |
203,36 |
241,43 |
Janssen-Cilag International NV
|
|
29815.06.01
|
XEPLION INJ.SU.PRO 100MG/PF.SYR Συσκευασία έναρξης θεραπείας BTx1PF.SYRx150MG+2 βελόνες + BTx1PF.SYRx100MG+2 βελόνες
|
|
665,23 |
739,87 |
835,24 |
Janssen-Cilag International NV
|
|
29815.05.01
|
XEPLION INJ.SU.PRO 150MG/PF.SYR BTx1PF.SYRx150MG +2 βελόνες +2 βελόνες
|
|
270,19 |
300,51 |
350,39 |
Janssen-Cilag International NV
|
|
29815.02.01
|
XEPLION INJ.SU.PRO 50MG/PF.SYR BTx1PF.SYRx50MG +2 βελόνες
|
|
148,77 |
171,01 |
206,65 |
Janssen-Cilag International NV
|
|
29815.03.01
|
XEPLION INJ.SU.PRO 75MG/PF.SYR BTx1PF.SYRx75MG +2 βελόνες +2 βελόνες
|
|
143,51 |
164,96 |
199,33 |
Janssen-Cilag International NV
|
|
26025.01.01
|
ZAVESCA CAPS 100MG/CAP BTx84(BLIST4x21)
|
|
3.045,12 |
3.386,80 |
3.661,81 |
Janssen-Cilag International NV
|
|
30006.02.02
|
ZYTIGA F.C.TAB 500MG/TAB BTx5 BLISTERS χάρτινες αναδιπλούμενες θήκες (PVDC/PE/PVC/αλουμίνιο) x12 δισκία (60 δισκία)
|
|
2.092,08 |
2.326,83 |
2.534,27 |
Janssen-Cilag International NV
|
|
30006.01.01
|
ZYTIGA TAB 250MG/TAB ΦΙΑΛΗ (HDPE)x120 ΔΙΣΚΙΑ ΔΙΣΚΙΑ
|
|
2.521,66 |
2.804,61 |
3.039,77 |
Janssen-Cilag International NV
|
